Russell Basser
Directeur/Membre du Conseil chez STARPHARMA HOLDINGS LIMITED
Profil
Russell Basser is currently a Director at Medical Developments International Ltd., an Independent Non-Executive Director at Starpharma Holdings Ltd., and the Chief Medical Officer at CSL Ltd.
(United States).
Previously, he worked at CSL Behring LLC as the Senior VP-Global Clinical Research & Development from 2014 to 2022.
Basser received his undergraduate and doctorate degrees from the University of Melbourne.
Postes actifs de Russell Basser
| Sociétés | Poste | Début |
|---|---|---|
| STARPHARMA HOLDINGS LIMITED | Directeur/Membre du Conseil | 20/02/2023 |
| MEDICAL DEVELOPMENTS INTERNATIONAL LIMITED | Directeur/Membre du Conseil | 01/09/2023 |
| CSL Ltd. (United States) | Directeur Technique/Scientifique/R&D | - |
Anciens postes connus de Russell Basser
| Sociétés | Poste | Fin |
|---|---|---|
CSL Behring LLC
 CSL Behring LLC BiotechnologyHealth Technology CSL Behring LLC researches, develops, manufactures, and markets biotherapies that are used to treat serious and rare conditions. It offers protein-based therapies in the areas of Bleeding Disorders, Fluid Replacement, Hereditary Angioedema, Immunoglobulin, Pulmonary, and Wound Healing Therapies. The company was founded in 2004 and is headquartered in King of Prussia, PA. | Directeur Technique/Scientifique/R&D | 01/04/2022 |
Formation de Russell Basser
| University of Melbourne | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| STARPHARMA HOLDINGS LIMITED | Health Technology |
| MEDICAL DEVELOPMENTS INTERNATIONAL LIMITED | Health Technology |
| Entreprise privées | 2 |
|---|---|
CSL Behring LLC
CSL Behring LLC BiotechnologyHealth Technology CSL Behring LLC researches, develops, manufactures, and markets biotherapies that are used to treat serious and rare conditions. It offers protein-based therapies in the areas of Bleeding Disorders, Fluid Replacement, Hereditary Angioedema, Immunoglobulin, Pulmonary, and Wound Healing Therapies. The company was founded in 2004 and is headquartered in King of Prussia, PA. | Health Technology |
| CSL Ltd. (United States) |
